Proton Pump Inhibitors and ASA in the Treatment of Barrett's Esophagus Comment

被引：0
|
作者：
Labenz, Joachim [1 ]
机构：
[1] Diakonie Klinikum, Stuttgart, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2018年 / 143卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1590 / +
页数：2
相关论文
共 50 条
  • [41] Esophageal and gastric pH in patients with gastroesophageal reflux disease and Barrett's esophagus treated with proton pump inhibitors
    Gerson, LB
    Boopari, V
    Ullah, N
    Triadafilopoulos, G
    GASTROENTEROLOGY, 2004, 126 (04) : A57 - A57
  • [42] Regression of Barrett's esophagus with high dose proton pump inhibitor therapy
    Barrett, KA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S30 - S31
  • [43] Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma
    Samuels, Tina L.
    Altman, Kenneth W.
    Gould, Jon C.
    Kindel, Tammy
    Bosler, Matthew
    MacKinnon, Alexander
    Hagen, Catherine E.
    Johnston, Nikki
    LARYNGOSCOPE, 2019, 129 (12): : 2687 - 2695
  • [44] Barrett's esophagus: How much acid suppression is enough? Predictors of response to high dose proton pump inhibitors
    Maqbool, S
    Bhat, YM
    Khandwala, F
    Vaezi, MF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S10 - S10
  • [45] Can we normalize esophageal acid and bile exposure in patients with Barrett's esophagus using proton pump inhibitors?
    Ours, TM
    Falk, GW
    Richter, JE
    Vaezi, MF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S22 - S22
  • [46] Proton Pump Inhibitors and the Risk of Neoplastic Progression in Barrett's Esophagus: Results of a Large Multicenter Prospective Cohort Study
    Kastelein, Florine
    Spaander, Manon
    Biermann, Katharina
    Steyerberg, Ewout W.
    Geldof, Han
    ter Borg, Pieter
    Lesterhuis, Wilco
    Klinkenberg-Knol, Elly C.
    ter Borg, Frank
    Kolkman, Jeroen J.
    den Hartog, Gijsbert
    van Tilburg, Antonie J. P.
    Tan, Gie
    Peters, Frans T.
    Schenk, Ed
    Engels, Leopold G.
    Kulpers, Ernst J.
    Bruno, Marco J.
    GASTROENTEROLOGY, 2011, 140 (05) : S218 - S218
  • [47] Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with use of proton-pump inhibitors (PPIs) or aspirin/NSAIDs
    Siersema, PD
    Yu, S
    Sahbaie, P
    Simpson, P
    Steyerberg, EW
    Kuipers, EJ
    Triadafilopoulos, G
    GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB259 - AB259
  • [48] The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus
    Bozikas, A.
    Marsman, W. A.
    Rosmolen, W. D.
    van Baal, J. W. P. M.
    Kulik, W.
    ten Kate, F. J. W.
    Krishnadath, K. K.
    Bergman, J. J. G. H. M.
    DISEASES OF THE ESOPHAGUS, 2008, 21 (04) : 346 - 354
  • [49] Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing
    Kuipers, Ernst J.
    GUT, 2010, 59 (02) : 148 - 149
  • [50] Proton pump inhibitor therapy delays the development of dysplasia in patients with Barrett's esophagus
    Clarke, A
    Hillman, L
    Chiragakis, L
    Kaye, G
    Shadbolt, B
    GASTROENTEROLOGY, 2002, 122 (04) : A293 - A293
12345